Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
Coletti, Yang, Marazzi, Sassoon: TNFalpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways. in The EMBO journal 2002
Show all 2 Pubmed References
Doostzadeh-Cizeron, Yin, Goodrich: Apoptosis induced by the nuclear death domain protein p84N5 is associated with caspase-6 and NF-kappa B activation. in The Journal of biological chemistry 2000
Show all 2 Pubmed References
The bactericidal activity of caspase-6-/- macrophages was impaired compared to wild type cells. Caspase-6-/- mice showed higher expression of the IL-1b (show IL1B ELISA Kits) gene, known to be detrimental in murine melioidosis. Expression of the IL-10 (show IL10 ELISA Kits) gene was also increased in caspase-6-/- mice as early as 6 hours after infection. Treatment with exogenous IL-10 (show IL10 ELISA Kits) rendered mice more susceptible against B. pseudomallei challenge
caspase-6 could regulate breast cancer cell invasion by modulating MMP-2 (show MMP2 ELISA Kits) and MMP-9 (show MMP9 ELISA Kits) expression in 4T1 tumor-associated macrophages
Casp6 is unlikely to be involved in colitis-associated tumors.
p53 (show TP53 ELISA Kits) activity is an important upstream regulator of caspase-6 activity in muscle tissue.
TNFalpha (show TNF ELISA Kits)-induced RIP1 (show RALBP1 ELISA Kits)-independent caspase-6 activation was involved in regulating the relationship between autophagy and necroptosis.
CASP6 released from axonal terminals regulates microglial TNF-alpha (show TNF ELISA Kits) secretion, synaptic plasticity, and inflammatory pain.
both Caspase-3 (show CASP3 ELISA Kits) and Caspase-6 are implicated in axon degeneration that occurs as a part of normal development.
Casp6-/- neurons are protected against excitotoxicity, nerve growth factor deprivation and myelin-induced axonal degeneration. Furthermore, Casp6-deficient mice show an age-dependent increase in cortical and striatal volume.
This study demonistrated that elimination of caspase-6 protein and activity in the BACHD mouse model does not prevent the production of a 586 aa Htt (show HTT ELISA Kits) proteolytic fragment in the brain.
Neutrophil/macrophage contact activates CASP-6, producing interleukin-1 receptor-associated kinase-M (show IRAK3 ELISA Kits) (IRAK-M (show IRAK3 ELISA Kits)) cleavage and de-repression of alveolar macrophages; CASP-6 deletion protects mice from death caused by bacterial peritonitis.
Results support the possibility that the Casp6 activity in the anterior olfactory nucleus of the olfactory bulb reflects degeneration in the entorhinal cortex and suggest that Casp6 activity in the olfactory bulb could represent degeneration associated with cognitive decline and early Alzheimer disease.
These data suggest that caspase-6 deactivating mutations may contribute to multifactorial carcinogenic transformations.
Caspase-6 undergoes helix-strand transition upon substrate binding. Caspase-6 shows distinctive conformational dynamics in its 130's region Local pKa Values of Key Amino Acid Residues within the 130's Region Vary between the Unliganded (Helical) and the VEID-bound (Strand) States of Caspase-6 .
Following specific binding to and internalization into HER2 (show ERBB2 ELISA Kits)-overexpressing tumor cells, the e23sFv-Fdt-casp6 protein induced tumor cell apoptosis and inhibited the proliferation of HER2 (show ERBB2 ELISA Kits)-overexpressing A172 and U251MG cells in vitro, but not in U87MG cells with undetectable HER2 (show ERBB2 ELISA Kits)
Results identified novel members of the CASP6 interactome and demonstrate that a number of them are involved in key signaling pathways observed in neurodegenerative diseases.
The ability of sox11 (show SOX11 ELISA Kits) to reduce effector caspase (show CASP3 ELISA Kits) activity was also reflected in its capacity to reduce cell death following toxic insult. Interestingly, other sox (show PIPOX ELISA Kits) proteins also had the ability to reduce caspase-6 activity but to a lesser extent than sox11 (show SOX11 ELISA Kits)
Caspase-6 plays a role in activating caspase-3 (show CASP3 ELISA Kits) in Tau truncation.
unmodified STAT1 (show STAT1 ELISA Kits) is cleaved at multiple sites by caspase-3 (show CASP3 ELISA Kits) and caspase-6 in malignant undifferentiated hematopoietic cells
p53 (show TP53 ELISA Kits) activity is an important upstream regulator of caspase-6 activity in Huntington's disease.
In this study, the crystal structure of a full-length CASP6 zymogen mutant, proCASP6H121A, was solved.
This gene encodes a protein which is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein is processed by caspases 7, 8 and 10, and is thought to function as a downstream enzyme in the caspase activation cascade. Alternative splicing of this gene results in two transcript variants that encode different isoforms.
, caspase 6, apoptosis-related cysteine protease
, caspase 6
, apoptotic protease Mch-2
, apoptotic protease MCH-2